OR WAIT null SECS
ATMI has invested in sterile-connector and sterile-fill technology developed by Medical Instill Technologies.
ATMI, a provider of single-use bioprocess solutions, has invested in sterile connector and sterile fill technology developed by Medical Instill Technologies (Medinstill), a provider of transfer and packaging solutions for high purity fluids at unmatched safety levels.
The investments focus on the INTACT family of products developed by Medinstill. These technologies will be deployed in sterile filling, sterile multiple-dose dispensing, sterile transfer, and packaging sterilization solutions.